Company research / LENZ
LENZ Therapeutics, Inc. (LENZ)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, LENZ Therapeutics, Inc. reported revenue of $19.09M.
Key ratios (year ended 2025-12-31)
-477.5%
Operating margin
-430.3%
Net margin
-28.9%
Return on year-end equity
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.